Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,53%
1 085,69
-5,82
-0,53%
—1 091,511 090,401 090,401 081,97——
SIXC
Communications
SIXC
Communications
SIXC
-0,38%
607,79
-2,32
-0,38%
—610,11610,11610,11606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,16%
1 239,91
+1,93
+0,16%
—1 237,981 237,831 241,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,11%
1 742,50
-2,21
-0,11%
—1 744,711 740,951 746,201 735,64——
SIXM
Financials
SIXM
Financials
SIXM
+0,10%
640,82
+0,64
+0,10%
—640,18639,92639,99636,70——
SIXR
Staples
SIXR
Staples
SIXR
+0,01%
849,70
+0,12
+0,01%
—849,58845,27849,28841,28——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0,05%
217,58
+0,10
+0,05%
—217,48217,48217,50216,39——
SIXT
Technology
SIXT
Technology
SIXT
+0,71%
3 283,71
+22,56
+0,71%
—3 260,693 273,363 286,293 269,07——
SIXU
Utilities
SIXU
Utilities
SIXU
+0,62%
948,33
+5,73
+0,62%
—942,45939,39947,44934,04——
SIXV
Health care
SIXV
Health care
SIXV
-0,12%
1 465,06
-1,74
-0,12%
—1 466,801 464,701 466,471 458,68——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,02%
2 398,01
+0,51
+0,02%
—2 397,502 395,032 404,632 391,98——
HALO:NASDAQ
Halozyme Therapeutics, Inc.
64,40 US$
+0,68%
(+0,43) 1D
4 მაი, 10:29:29 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HALO...
Open
63,50 US$
High
64,68 US$
Low
63,11 US$
Mkt. cap
7,65 მლრდ.
Volume
81,18 ათ.
P/E ratio
25,18
52-wk high
82,22 US$
52-wk low
47,50 US$
EPS
2,56 US$
Beta
0,89
Shares outstanding
118,47 მლნ.
No. of employees
423
News stories
From sources across the web
Profile
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California. Wikipedia
About Halozyme Therapeutics, Inc.
CEOჰელენ აი ტორლი
Employees423
Founded1998
Headquartersსან-დიეგო, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websitehalozyme.com
Next call 7 დღეში
ორშ, 11 მაი, 16:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (1,52 est.)USD
Revenue / Estimate
-/ (359,05 მლნ. est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
264,86 მლნ.
325,72 მლნ.
354,26 მლნ.
451,77 მლნ.
Cost of goods sold
63,20 მლნ.
46,36 მლნ.
72,49 მლნ.
110,67 მლნ.
Cost of revenue
63,20 მლნ.
46,36 მლნ.
72,49 მლნ.
110,67 მლნ.
Research and development expenses
-
17,54 მლნ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
42,36 მლნ.
41,61 მლნ.
46,09 მლნ.
63,33 მლნ.
Operating expense
60,12 მლნ.
76,92 მლნ.
63,85 მლნ.
86,70 მლნ.
Total operating expenses
123,33 მლნ.
123,28 მლნ.
136,34 მლნ.
197,37 მლნ.
Operating income
141,54 მლნ.
202,44 მლნ.
217,92 მლნ.
254,40 მლნ.
Other non operating income
-
6,89 მლნ.
-
-
EBT including unusual items
143,83 მლნ.
204,94 მლნ.
218,96 მლნ.
-100,85 მლნ.
EBT excluding unusual items
142,12 მლნ.
204,94 მლნ.
218,96 მლნ.
251,58 მლნ.
Income tax expense
25,73 მლნ.
39,78 მლნ.
43,73 მლნ.
40,74 მლნ.
Effective tax rate
17,89%
19,41%
19,97%
-40,40%
Other operating expenses
-
-
-
-
Net income
118,10 მლნ.
165,16 მლნ.
175,22 მლნ.
-141,59 მლნ.
Net profit margin
44,59%
50,71%
49,46%
-31,34%
Earnings per share
1,11
1,54
1,72
-0,24
Interest and investment income
5,11 მლნ.
-
5,33 მლნ.
2,09 მლნ.
Interest expense
-4,52 მლნ.
-4,39 მლნ.
-4,30 მლნ.
-4,91 მლნ.
Net interest expenses
584,00 ათ.
-4,39 მლნ.
1,04 მლნ.
-2,82 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
160,48 მლნ.
221,44 მლნ.
236,84 მლნ.
279,08 მლნ.
Gain or loss from assets sale
-
-
-
2,62 მლნ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer